UK Parliament home

Open Fund NHS access to Lecanemab & Donanemab to slow dementia/Alzheimer's symptoms

Created by Joanne Sarah Louise Harrigan
Closes on

We call on the Government to fund NHS access to Lecanemab & Donanemab on prescription for those with early-onset dementia, Familial Alzheimer's Disease and those who are asymptomatic, but carry a genetic mutation that will result in early onset Dementia.

Lecanemab & Donanemab are drugs licensed by the UK’s MHRA, for the treatment of mild Alzheimer's symptoms. It is clinically proven to slow the progression of Alzheimer's disease. Clinical trials showed they slowed the onset of people with early Alzheimer’s Disease.

Nearly 1 million people live with Dementia in the UK, costing the economy an estimated £42 million per year.

Familial Alzheimer’s disease accounts for less than 1% of all Dementia cases. People who carry that genetic mutation will develop Alzheimer’s Disease symptoms before the age of 65.

Sign this petition

591 signatures

Show on a map

10,000

Petition progress

View all updates for this petition, with the most recent first.

  • Petition published

    This petition can now be signed.

    If this petition gets 10,000 signatures, government will respond to it.

    If this petition gets 100,000 signatures, it will be considered for debate in Parliament.

    This petition will stay open until 21 February 2027.